{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T23:39:36Z","timestamp":1792366776237,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":94,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hebei Province Finance Department Project","award":["ZF2025062"],"award-info":[{"award-number":["ZF2025062"]}]},{"name":"Industry University Research Cooperation Special Project","award":["CXZX2025030"],"award-info":[{"award-number":["CXZX2025030"]}]},{"name":"Key Science and Technology Research Program of Hebei Provincial Health Commission","award":["GZ2023010"],"award-info":[{"award-number":["GZ2023010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-62729-3","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:45:45Z","timestamp":1784263545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of PCSK9 protects against myocardial ischemia-reperfusion injury by suppressing ferroptosis via negative regulation of the P65\/MMP9 pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Jianan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tixin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4300-0209","authenticated-orcid":false,"given":"Mingqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"10258","key":"62729_CR1","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"Global burden","year":"2020","unstructured":"Global burden. of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396 (10258), 1223\u20131249 (2020).","journal-title":"Lancet"},{"issue":"2","key":"62729_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1001\/jama.2022.9600","volume":"328","author":"N Eldridge","year":"2022","unstructured":"Eldridge, N. et al. Krumholz, Trends in Adverse Event Rates in Hospitalized Patients, 2010\u20132019. Jama 328 (2), 173\u2013183 (2022).","journal-title":"Jama"},{"issue":"9","key":"62729_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s12471-018-1134-0","volume":"26","author":"F Arslan","year":"2017","unstructured":"Arslan, F. et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the Dutch ACS working group. Neth. Heart J. 26 (9), 417\u2013421 (2017).","journal-title":"Neth. Heart J."},{"issue":"7","key":"62729_CR4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/jama.2022.0358","volume":"327","author":"DL Bhatt","year":"2022","unstructured":"Bhatt, D. L., Lopes, R. D. & Harrington, R. A. Diagnosis and Treatment of Acute Coronary Syndromes: A Review. Jama 327 (7), 662\u2013675 (2022).","journal-title":"Jama"},{"issue":"11","key":"62729_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMra071667","volume":"357","author":"DM Yellon","year":"2007","unstructured":"Yellon, D. M. & Hausenloy, D. J. Myocardial reperfusion injury. N Engl. J. Med. 357 (11), 1121\u20131135 (2007).","journal-title":"N Engl. J. Med."},{"issue":"12","key":"62729_CR6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"Heusch, G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat. Rev. Cardiol. 17 (12), 773\u2013789 (2020).","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"62729_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41569-019-0260-8","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Murugesan, P., Huang, K. & Cai, H. NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets. Nat. Rev. Cardiol. 17 (3), 170\u2013194 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"62729_CR8","doi-asserted-by":"publisher","first-page":"1632867","DOI":"10.3389\/fgene.2025.1632867","volume":"16","author":"Q Pang","year":"2025","unstructured":"Pang, Q. et al. Temporal regulation of genetic programs governing multiple cell death during myocardial ischemia-reperfusion injury. Front. Genet. 16, 1632867 (2025).","journal-title":"Front. Genet."},{"issue":"4","key":"62729_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00439-003-1071-9","volume":"114","author":"KM Timms","year":"2004","unstructured":"Timms, K. M. et al. A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree. Hum. Genet. 114 (4), 349\u2013353 (2004).","journal-title":"Hum. Genet."},{"issue":"3","key":"62729_CR10","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1210\/endrev\/bnab035","volume":"43","author":"NG Seidah","year":"2022","unstructured":"Seidah, N. G. & Prat, A. The Multifaceted Biology of PCSK9. Endocr. Rev. 43 (3), 558\u2013582 (2022).","journal-title":"Endocr. Rev."},{"issue":"6","key":"62729_CR11","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1073\/pnas.0409736102","volume":"102","author":"KN Maxwell","year":"2005","unstructured":"Maxwell, K. N., Fisher, E. A. & Breslow, J. L. Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. Proc. Natl. Acad. Sci. U S A. 102 (6), 2069\u20132074 (2005).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"18","key":"62729_CR12","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1073\/pnas.0402133101","volume":"101","author":"KN Maxwell","year":"2004","unstructured":"Maxwell, K. N. & Breslow, J. L. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. Proc. Natl. Acad. Sci. U S A. 101 (18), 7100\u20137105 (2004).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"6","key":"62729_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00395-020-00832-w","volume":"115","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. PCSK9 regulates pyroptosis via mtDNA damage in chronic myocardial ischemia. Basic. Res. Cardiol. 115 (6), 66 (2020).","journal-title":"Basic. Res. Cardiol."},{"issue":"15","key":"62729_CR14","first-page":"3","volume":"39","author":"V Quagliariello","year":"2021","unstructured":"Quagliariello, V. et al. PCSK9 inhibitor evolocumab to increase anticancer activities and reduce cardiotoxicity during doxorubicin and trastuzumab, as sequential treatment, through MyD88\/NF-kB\/mTORC1 pathways. J. Clin. Oncol. 39 (15), 3 (2021).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"62729_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang, X., Ardehali, H., Min, J. & Wang, F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat. Rev. Cardiol. 20 (1), 7\u201323 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"62729_CR16","doi-asserted-by":"publisher","first-page":"116057","DOI":"10.1016\/j.biopha.2023.116057","volume":"170","author":"G Liu","year":"2024","unstructured":"Liu, G. et al. Ferroptosis in cardiovascular disease. Biomed. Pharmacother. 170, 116057 (2024).","journal-title":"Biomed. Pharmacother"},{"issue":"1","key":"62729_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41392-023-01688-x","volume":"9","author":"M Zhang","year":"2024","unstructured":"Zhang, M. et al. Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Signal. Transduct. Target. Ther. 9 (1), 12 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"10","key":"62729_CR18","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","volume":"19","author":"Y Xie","year":"2023","unstructured":"Xie, Y., Kang, R., Klionsky, D. J. & Tang, D. GPX4 in cell death, autophagy, and disease. Autophagy 19 (10), 2621\u20132638 (2023).","journal-title":"Autophagy"},{"issue":"5","key":"62729_CR19","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149 (5), 1060\u20131072 (2012).","journal-title":"Cell"},{"issue":"3","key":"62729_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang, W. S. & Stockwell, B. R. Ferroptosis: Death by Lipid Peroxidation. Trends Cell. Biol. 26 (3), 165\u2013176 (2016).","journal-title":"Trends Cell. Biol."},{"key":"62729_CR21","unstructured":"Shao, N. et al. Ferritinophagy and organ injury, Autophagy 1\u201315. (2026)."},{"issue":"2","key":"62729_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li, J. et al. Ferroptosis: past, present and future. Cell. Death Dis. 11 (2), 88 (2020).","journal-title":"Cell. Death Dis."},{"issue":"9","key":"62729_CR23","doi-asserted-by":"publisher","first-page":"110622","DOI":"10.1016\/j.isci.2024.110622","volume":"27","author":"FI Gawargi","year":"2024","unstructured":"Gawargi, F. I. & Mishra, P. K. MMP9 drives ferroptosis by regulating GPX4 and iron signaling. iScience 27 (9), 110622 (2024).","journal-title":"iScience"},{"key":"62729_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1182\/blood-2021-146157","volume":"138","author":"E Federti","year":"2021","unstructured":"Federti, E. et al. Nrf2 Plays a Key Role in Iron-Overload Cardiomyopathy. Blood 138, 3 (2021).","journal-title":"Blood"},{"key":"62729_CR25","doi-asserted-by":"crossref","unstructured":"Vandergriff, A. C., Hensley, M. T. & Cheng, K. Isolation and cryopreservation of neonatal rat cardiomyocytes. J. Vis. Exp. (98) (2015).","DOI":"10.3791\/52726-v"},{"issue":"2","key":"62729_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nprot.2006.98","volume":"1","author":"TI Lee","year":"2006","unstructured":"Lee, T. I., Johnstone, S. E. & Young, R. A. Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat. Protoc. 1 (2), 729\u2013748 (2006).","journal-title":"Nat. Protoc."},{"issue":"D1","key":"62729_CR27","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44 (D1), D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"62729_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"62729_CR29","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013d677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"62729_CR30","doi-asserted-by":"publisher","first-page":"tkae068","DOI":"10.1093\/burnst\/tkae068","volume":"13","author":"R Song","year":"2025","unstructured":"Song, R. et al. Receptor activity-modifying protein 1 regulates the differentiation of mouse skin fibroblasts by downregulating \u03b1-SMA expression via suppression of high mobility group AT-hook 1 to promote skin wound repair. Burns Trauma. 13, tkae068 (2025).","journal-title":"Burns Trauma."},{"issue":"10332","key":"62729_CR31","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0140-6736(21)02391-6","volume":"399","author":"BA Bergmark","year":"2022","unstructured":"Bergmark, B. A., Mathenge, N., Merlini, P. A., Lawrence-Wright, M. B. & Giugliano, R. P. Acute coronary syndromes. Lancet 399 (10332), 1347\u20131358 (2022).","journal-title":"Lancet"},{"issue":"13","key":"62729_CR32","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/cvr\/cvy128","volume":"114","author":"Z Ding","year":"2018","unstructured":"Ding, Z. et al. PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy. Cardiovasc. Res. 114 (13), 1738\u20131751 (2018).","journal-title":"Cardiovasc. Res."},{"key":"62729_CR33","doi-asserted-by":"crossref","unstructured":"Zhou, R. et al. Genetic associations of circulating plasma proteins with cardiometabolic diseases. Genome Biol. 27(1) (2026).","DOI":"10.1186\/s13059-026-03962-x"},{"issue":"1","key":"62729_CR34","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s42003-024-06674-9","volume":"7","author":"A Ghalali","year":"2024","unstructured":"Ghalali, A. et al. Contrasting effects of intracellular and extracellular human PCSK9 on inflammation, lipid alteration and cell death. Commun. Biol. 7 (1), 985 (2024).","journal-title":"Commun. Biol."},{"issue":"4","key":"62729_CR35","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1002\/jcp.30025","volume":"236","author":"Y Guo","year":"2021","unstructured":"Guo, Y. et al. Physiology and role of PCSK9 in vascular disease: Potential impact of localized PCSK9 in vascular wall. J. Cell. Physiol. 236 (4), 2333\u20132351 (2021).","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"62729_CR36","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1210\/en.2008-1281","volume":"150","author":"L Persson","year":"2009","unstructured":"Persson, L., G\u00e4lman, C., Angelin, B. & Rudling, M. Importance of proprotein convertase subtilisin\/kexin type 9 in the hormonal and dietary regulation of rat liver low-density lipoprotein receptors. Endocrinology 150 (3), 1140\u20131146 (2009).","journal-title":"Endocrinology"},{"issue":"2","key":"62729_CR37","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/hep.22354","volume":"48","author":"A Zaid","year":"2008","unstructured":"Zaid, A. et al. Proprotein convertase subtilisin\/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration. Hepatology 48 (2), 646\u2013654 (2008).","journal-title":"Hepatology"},{"issue":"12","key":"62729_CR38","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1194\/jlr.R026658","volume":"53","author":"G Lambert","year":"2012","unstructured":"Lambert, G., Sjouke, B., Choque, B., Kastelein, J. J. & Hovingh, G. K. The PCSK9 decade. J. Lipid Res. 53 (12), 2515\u20132524 (2012).","journal-title":"J. Lipid Res."},{"issue":"32","key":"62729_CR39","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1093\/eurheartj\/ehab431","volume":"42","author":"L Da Dalt","year":"2021","unstructured":"Da Dalt, L. et al. PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction. Eur. Heart J. 42 (32), 3078\u20133090 (2021).","journal-title":"Eur. Heart J."},{"issue":"2","key":"62729_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4149\/gpb_2019057","volume":"39","author":"CL Yang","year":"2020","unstructured":"Yang, C. L., Zeng, Y. D., Hu, Z. X. & Liang, H. PCSK9 promotes the secretion of pro-inflammatory cytokines by macrophages to aggravate H\/R-induced cardiomyocyte injury via activating NF-\u03baB signalling. Gen. Physiol. Biophys. 39 (2), 123\u2013134 (2020).","journal-title":"Gen. Physiol. Biophys."},{"issue":"5","key":"62729_CR41","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1046\/j.1365-2362.1999.00481.x","volume":"29","author":"A Saraste","year":"1999","unstructured":"Saraste, A. et al. Voipio-Pulkki, Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur. J. Clin. Invest. 29 (5), 380\u2013386 (1999).","journal-title":"Eur. J. Clin. Invest."},{"issue":"40","key":"62729_CR42","doi-asserted-by":"publisher","first-page":"e1902900","DOI":"10.1002\/adma.201902900","volume":"31","author":"C Fan","year":"2019","unstructured":"Fan, C. et al. Myocardial-Infarction-Responsive Smart Hydrogels Targeting Matrix Metalloproteinase for On-Demand Growth Factor Delivery. Adv. Mater. 31 (40), e1902900 (2019).","journal-title":"Adv. Mater."},{"key":"62729_CR43","doi-asserted-by":"crossref","unstructured":"Schreckenberg, R. et al. Proprotein convertase subtilisin kexin type 9 (PCSK9) deletion but not inhibition of extracellular PCSK9 Reduces infarct sizes ex vivo but not in vivo. Int. J. Mol. Sci. 23(12) (2022).","DOI":"10.3390\/ijms23126512"},{"issue":"6","key":"62729_CR44","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1161\/CIRCRESAHA.112.276915","volume":"112","author":"H Ling","year":"2013","unstructured":"Ling, H. et al. Ca2+\/Calmodulin-dependent protein kinase II \u03b4 mediates myocardial ischemia\/reperfusion injury through nuclear factor-\u03baB. Circ. Res. 112 (6), 935\u2013944 (2013).","journal-title":"Circ. Res."},{"key":"62729_CR45","doi-asserted-by":"publisher","first-page":"104744","DOI":"10.1016\/j.ebiom.2023.104744","volume":"95","author":"L Zhuang","year":"2023","unstructured":"Zhuang, L., Zong, X., Yang, Q., Fan, Q. & Tao, R. Interleukin-34-NF-\u03baB signaling aggravates myocardial ischemic\/reperfusion injury by facilitating macrophage recruitment and polarization. EBioMedicine 95, 104744 (2023).","journal-title":"EBioMedicine"},{"issue":"7","key":"62729_CR46","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41419-020-02777-3","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload. Cell. Death Dis. 11 (7), 574 (2020).","journal-title":"Cell. Death Dis."},{"issue":"10","key":"62729_CR47","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.1128\/MCB.17.10.6184","volume":"17","author":"Z Li","year":"1997","unstructured":"Li, Z. & Nabel, G. J. A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription. Mol. Cell. Biol. 17 (10), 6184\u20136190 (1997).","journal-title":"Mol. Cell. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62729-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62729-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62729-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:48:58Z","timestamp":1792363738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62729-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["62729"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-62729-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. This study was approved by the Institutional Review Board of The First Hospital of Hebei Medical University (Approval No. 2023-S01013). All experiments involving animals complied with relevant ethical guidelines. The experimental design was approved by the Animal Protection and Use Committee of Hebei Medical University (Hebei, China) (Approval No. IACUC-Hebmu-2024139). SD rats were obtained from Beijing Bio-Gate Biotech Co., Ltd.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Artificial Intelligence was not used in this work.","order":4,"name":"Ethics","label":"Disclosure <b>statement for artificial intelligence<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"32735"}}